[Rapport de recherche]Le marché des vaccins pour la volaille devrait passer de 1 844,89 millions de dollars US en 2021 à 2 845,00 millions de dollars US d'ici 2028 ; on estime qu'il augmentera à un TCAC de 6,4 % de 2021 à 2028.
L'industrie de la volaille aux États-Unis est le plus grand producteur et le deuxième exportateur mondial de viande de volaille ; c'est aussi un important producteur d'ufs dans le monde. Le pays signale une consommation plus élevée de viande de volaille (poulets de chair, autres races de poulets et dinde) que de buf ou de porc. Il exporte environ 18 % du total des produits avicoles et est fortement influencé par les fluctuations monétaires, les négociations commerciales et la croissance économique des marchés d'importation.
Selon les données publiées par le département américain de (USDA), le pays a enregistré une consommation de produits avicoles par habitant de 107,6 livres en 2016, qui est passée à 113 livres en 2021. Cette augmentation de la production et de la consommation est l'un des facteurs qui stimulent le marché de la santé de la volaille. Les progrès technologiques dans la fabrication de vaccins stimulent également le marché mondial des vaccins pour volaille. Par exemple, en 2020, Boehringer Ingelheims Animal Health Business aux États-Unis a lancé le vaccin VAXXITEK HVT+IBD+ND qui protège les volailles contre trois maladies : la maladie de Mareks, la bursite infectieuse (types classiques et variants) et la maladie de Newcastle. L'entreprise fabrique 60 milliards de doses de vaccins pour volailles en un an pour une utilisation aux États-Unis et dans plus de 60 autres pays, dont l'Allemagne, l'Italie, la Chine et le Japon. En 2020, Zoetis a élargi sa gamme de vaccins pour volailles avec l'introduction de Poulvac Procerta HVT-ND, un type de vaccin recombinant vectoriel qui protège les poulets de chair contre les maladies de Newcastle et de Mareks.
Stratégique Insights
Les vaccins pour volailles sont des composants biologiques (antigènes) qui fournissent une immunité acquise active contre des maladies spécifiques de la volaille. Une autre raison de la vaccination des troupeaux de volailles est l'hyper-immunisation des poules pour augmenter les niveaux d'anticorps générés par la mère qui sont transférés par un uf à la progéniture à couver.
Aperçu du marchéAugmentation de la prévalence des maladies chez la volaille Stimuler la croissance du marché des vaccins pour volaille
Le vaccin pour volaille aide à prévenir une maladie spécifique en accélérant le système immunitaire de l'oiseau pour générer des anticorps pour lutter contre les organismes envahisseurs. Les vaccins aviaires sont essentiels pour le contrôle des maladies aviaires et la prévention des maladies virales. La vaccination aide à prévenir ou à réduire les effets indésirables de conditions spécifiques qui peuvent causer des problèmes, comme les infections dans un troupeau de volailles. Les vaccins aviaires sont largement appliqués pour éviter les maladies contagieuses de la volaille et minimiser l'émergence de maladies cliniques au niveau de la ferme, augmentant ainsi la production. Les maladies zoonotiques, les virus de la grippe aviaire et la grippe aviaire sont les principales maladies de la volaille.
Par exemple, dans 24 pays de l'UE/EEE et au Royaume-Uni, 1 672 influenza aviaire hautement pathogène (IAHP) des détections de virus ont été enregistrées chez des volailles (n = 580), des oiseaux sauvages (n = 1 051) et des oiseaux captifs (n = 41) entre février et mai 2021. La Pologne a détecté 297 foyers dans la région à forte population de volailles pendant une courte période, suivie par l'Allemagne avec 168 incidents. La plupart des flambées de grippe chez les volailles semblaient être liées à la transmission inter-élevages et au trafic intra-communautaire de poulets vivants infectés par l'influenza aviaire hautement pathogène (IAHP). L'Allemagne a ouvert la voie avec 603 détections d'oiseaux sauvages, suivie du Danemark et de la Pologne avec 167 et 56, respectivement. Le deuxième pic de mortalité des oiseaux sauvages associé à l'IAHP a été observé de février à avril 2021 dans le nord-ouest de l'Europe.
En 2020, le ministère français de l'Agriculture a confirmé l'infection d'un virus hautement pathogène Influenza aviaire H5N8 sur 6 000 canards d'un élevage de canards à Benesse-Mariamne dans les Landes. Le pays a déjà détecté l'infection par le virus H5N8 parmi des oiseaux vendus dans trois animaleries à la mi-novembre 2020. De plus, l'Arabie saoudite a signalé une épidémie de virus de la grippe aviaire H5N8 hautement pathogène dans un élevage de volailles. L'émergence s'est produite dans la région centrale de Sudair et a tué 22 700 oiseaux. Les 385 300 autres oiseaux du troupeau ont été abattus. Il s'agissait de la première épidémie du virus H5N8 en Arabie saoudite depuis juillet 2018. Ainsi, le nombre croissant de diverses maladies de la volaille maximise la demande de vaccins pour les poulets, stimulant ainsi la croissance du marché des vaccins pour la volaille.
Aperçus basés sur la maladie
Sur la base de la maladie, le marché mondial des vaccins pour la volaille est segmenté en bronchite infectieuse, grippe aviaire, maladie de Mareks, bursite infectieuse, maladie de Newcastle , salmonellose et autres. Le segment de la maladie de Newcastle détenait la plus grande part du marché en 2021, tandis que le segment de la grippe aviaire devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.
Marché des vaccins pour volaille, par maladie - 2021-2028
Les acteurs du marché mondial des vaccins pour volaille adoptent des stratégies organiques telles que le lancement et l'expansion de produits pour étendre leur empreinte et leur portefeuille de produits à l'échelle mondiale ainsi que pour répondre à la demande croissante de volaille produits vaccins. Les stratégies de croissance inorganique adoptées par ces acteurs comprennent des partenariats et des collaborations. Ces stratégies de croissance les aident dans l'expansion de leurs activités et de leur présence géographique. De plus, les stratégies de croissance telles que les acquisitions et les partenariats contribuent à renforcer la clientèle et à développer les portefeuilles de produits. Les stratégies biologiques représentent 60 % du total des développements stratégiques sur le marché mondial des vaccins pour la volaille, tandis que les stratégies inorganiques représentent 40 % de ces développements.
Le marché mondial des vaccins pour la volaille a été segmenté comme suit :
Le marché mondial des vaccins pour volailles est segmenté en fonction du type, de la technologie, de la forme posologique, de la voie d'administration, de la maladie et de l'utilisateur final. En fonction du type, le marché est segmenté en poulets de chair, pondeuses et reproducteurs. Le marché mondial des vaccins pour volailles, par technologie, est segmenté en vaccins vivants atténués, vaccins inactivés, vaccins recombinants et autres. Le marché, basé sur la forme posologique, est divisé en vaccins liquides, vaccins lyophilisés et vaccins en poussière/poudre. Le marché mondial des vaccins pour volailles, basé sur la voie d'administration, est divisé en eau potable et pulvérisation, intramusculaire, sous-cutanée et autres. Le marché, par utilisateur final, est divisé en fermes avicoles et couvoirs, hôpitaux vétérinaires et centres et cliniques de vaccination avicole.
Profils d'entreprise
- Boehringer Ingelheim International GmbH
- Zoetis Inc.
- Ceva Santé ; Animale
- BIOVAC
- Phibro Animal Health CorporationHester Biosciences Limited
- Venky's India
- Dechra Pharmaceuticals PLC
- Elanco
- Merck Santé Animale
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Poultry vaccines are biological components (antigens) that provide active or acquired or active immunity to specific diseases poultry. Vaccines are needed to develop active immunity to protect the poultry in a disease outbreak situation. Another reason for poultry flock vaccination is to hyper-immunize hens in order to increase the amount of maternally generated antibodies transferred through the egg to the hatching progeny.
The factors that are driving the growth of the market are increasing prevalence of diseases in poultry and increasing demand for healthy poultry food.
The Newcastle disease segment is expected to be the leading disease segment in the poultry vaccines market in 2021.
The breeder segment is expected to be the leading type segment in the poultry vaccines market in 2021.
The global poultry vaccines market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The largest market for poultry vaccines is held by the North American region. The United States held the largest market for poultry vaccines. The Asia-Pacific region is expected to be the fastest-growing region during the forecast period.
The poultry vaccines market majorly consists of the players such as Boehringer Ingelheim International GmbH; Zoetis Inc.; Ceva Santé Animale; BIOVAC; PHIBRO ANIMAL HEALTH CORPORATION; Hester Biosciences Limited; Venky's India; Dechra Pharmaceuticals PLC; Elanco; Merck Animal Health among others.
The List of Companies - Poultry Vaccine Market
- Boehringer Ingelheim International GmbH
- Zoetis Inc.
- Ceva Santé Animale
- BIOVAC
- Phibro Animal Health Corporation
- Hester Biosciences Limited
- Venky's India
- Dechra Pharmaceuticals PLC
- Elanco
- Merck Animal Health
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)